Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
Kronos Advanced Technologies Inc. owns all common shares and maintains full voting control of KronosMD Inc. Additionally, KronosMD’s preferred shareholders collectively hold over 5,000,000 shares with ...